OneMedNet (ONMD) Competitors

OneMedNet logo
$4.45 -0.50 (-10.10%)
Closing price 11/18/2026 04:00 PM Eastern
Extended Trading
$4.46 +0.00 (+0.11%)
As of 11/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ONMD vs. CCLD, HCAT, HIT, DRIO, and ITOC

Should you buy OneMedNet stock or one of its competitors? OneMedNet's main competitors and comparable companies include CareCloud (CCLD), Health Catalyst (HCAT), Health In Tech (HIT), DarioHealth (DRIO), and Itonic (ITOC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does OneMedNet compare to CareCloud?

CareCloud (NASDAQ:CCLD) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings, profitability and media sentiment.

CareCloud has a net margin of 7.36% compared to OneMedNet's net margin of -452.87%. CareCloud's return on equity of 36.92% beat OneMedNet's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud7.36% 36.92% 16.40%
OneMedNet -452.87%N/A -622.76%

10.2% of CareCloud shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 14.8% of CareCloud shares are held by insiders. Comparatively, 50.2% of OneMedNet shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

CareCloud has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$120.50M0.84$10.80M$0.1318.31
OneMedNet$1.36M20.29-$2.80M-$1.60N/A

CareCloud has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, CareCloud had 5 more articles in the media than OneMedNet. MarketBeat recorded 7 mentions for CareCloud and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.69 beat CareCloud's score of 0.34 indicating that OneMedNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CareCloud
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
OneMedNet
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

CareCloud beats OneMedNet on 11 of the 14 factors compared between the two stocks.

How does OneMedNet compare to Health Catalyst?

OneMedNet (NASDAQ:ONMD) and Health Catalyst (NASDAQ:HCAT) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

OneMedNet has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, Health Catalyst has a beta of 1.52, suggesting that its stock price is 52% more volatile than the broader market.

OneMedNet has higher earnings, but lower revenue than Health Catalyst. OneMedNet is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OneMedNet$1.36M20.29-$2.80M-$1.60N/A
Health Catalyst$272.21M0.36-$177.97M-$2.83N/A

In the previous week, Health Catalyst had 3 more articles in the media than OneMedNet. MarketBeat recorded 5 mentions for Health Catalyst and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.69 beat Health Catalyst's score of 0.52 indicating that OneMedNet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OneMedNet
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Health Catalyst
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Health Catalyst has a consensus price target of $2.01, suggesting a potential upside of 55.68%. Given Health Catalyst's stronger consensus rating and higher probable upside, analysts plainly believe Health Catalyst is more favorable than OneMedNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Health Catalyst
1 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.83

1.0% of OneMedNet shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 50.2% of OneMedNet shares are held by insiders. Comparatively, 19.4% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Health Catalyst has a net margin of -74.24% compared to OneMedNet's net margin of -452.87%. OneMedNet's return on equity of 0.00% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
OneMedNet-452.87% N/A -622.76%
Health Catalyst -74.24%-4.84%-2.02%

Summary

Health Catalyst beats OneMedNet on 8 of the 14 factors compared between the two stocks.

How does OneMedNet compare to Health In Tech?

Health In Tech (NASDAQ:HIT) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

In the previous week, Health In Tech had 16 more articles in the media than OneMedNet. MarketBeat recorded 18 mentions for Health In Tech and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.69 beat Health In Tech's score of -0.11 indicating that OneMedNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health In Tech
0 Very Positive mention(s)
4 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OneMedNet
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Health In Tech has a beta of 3.02, indicating that its stock price is 202% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market.

1.0% of OneMedNet shares are owned by institutional investors. 71.0% of Health In Tech shares are owned by insiders. Comparatively, 50.2% of OneMedNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

OneMedNet has lower revenue, but higher earnings than Health In Tech. OneMedNet is trading at a lower price-to-earnings ratio than Health In Tech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health In Tech$32.83M0.76-$12.45M-$0.19N/A
OneMedNet$1.36M20.29-$2.80M-$1.60N/A

Health In Tech has a net margin of 0.00% compared to OneMedNet's net margin of -452.87%.

Company Net Margins Return on Equity Return on Assets
Health In TechN/A N/A N/A
OneMedNet -452.87%N/A -622.76%

Health In Tech presently has a consensus price target of $3.50, suggesting a potential upside of 820.81%. Given Health In Tech's stronger consensus rating and higher probable upside, equities research analysts plainly believe Health In Tech is more favorable than OneMedNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health In Tech
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Health In Tech beats OneMedNet on 11 of the 15 factors compared between the two stocks.

How does OneMedNet compare to DarioHealth?

OneMedNet (NASDAQ:ONMD) and DarioHealth (NASDAQ:DRIO) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

OneMedNet has higher earnings, but lower revenue than DarioHealth. OneMedNet is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OneMedNet$1.36M20.29-$2.80M-$1.60N/A
DarioHealth$22.36M0.74-$41.71M-$3.90N/A

DarioHealth has a net margin of -159.85% compared to OneMedNet's net margin of -452.87%. OneMedNet's return on equity of 0.00% beat DarioHealth's return on equity.

Company Net Margins Return on Equity Return on Assets
OneMedNet-452.87% N/A -622.76%
DarioHealth -159.85%-53.07%-32.25%

1.0% of OneMedNet shares are held by institutional investors. Comparatively, 33.4% of DarioHealth shares are held by institutional investors. 50.2% of OneMedNet shares are held by company insiders. Comparatively, 3.5% of DarioHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

OneMedNet has a beta of 1.25, indicating that its stock price is 25% more volatile than the broader market. Comparatively, DarioHealth has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market.

In the previous week, DarioHealth had 10 more articles in the media than OneMedNet. MarketBeat recorded 12 mentions for DarioHealth and 2 mentions for OneMedNet. OneMedNet's average media sentiment score of 0.69 beat DarioHealth's score of 0.11 indicating that OneMedNet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OneMedNet
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
DarioHealth
0 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

DarioHealth has a consensus target price of $7.75, suggesting a potential upside of 430.82%. Given DarioHealth's stronger consensus rating and higher possible upside, analysts clearly believe DarioHealth is more favorable than OneMedNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
DarioHealth
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

DarioHealth beats OneMedNet on 8 of the 15 factors compared between the two stocks.

How does OneMedNet compare to Itonic?

OneMedNet (NASDAQ:ONMD) and Itonic (NASDAQ:ITOC) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Itonic
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

OneMedNet has higher revenue and earnings than Itonic.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OneMedNet$1.36M20.29-$2.80M-$1.60N/A
Itonic$520K22.10-$5.10MN/AN/A

OneMedNet has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, Itonic has a beta of 3.1, suggesting that its stock price is 210% more volatile than the broader market.

Itonic has a net margin of 0.00% compared to OneMedNet's net margin of -452.87%.

Company Net Margins Return on Equity Return on Assets
OneMedNet-452.87% N/A -622.76%
Itonic N/A N/A N/A

In the previous week, OneMedNet had 2 more articles in the media than Itonic. MarketBeat recorded 2 mentions for OneMedNet and 0 mentions for Itonic. OneMedNet's average media sentiment score of 0.69 beat Itonic's score of 0.00 indicating that OneMedNet is being referred to more favorably in the media.

Company Overall Sentiment
OneMedNet Positive
Itonic Neutral

1.0% of OneMedNet shares are owned by institutional investors. 50.2% of OneMedNet shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

OneMedNet beats Itonic on 6 of the 10 factors compared between the two stocks.

Get OneMedNet News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONMD vs. The Competition

MetricOneMedNetHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$30.70M$1.92B$7.72B$11.67B
Dividend YieldN/A3.89%2.47%4.53%
P/E RatioN/A39.4132.3627.90
Price / Sales20.295.208.285.57
Price / CashN/A15.5120.8521.62
Price / Book-7.674.594.443.72
Net Income-$2.80M-$19.09M$3.51B$394.03M
7 Day Performance-16.82%-7.41%-4.69%-4.67%
1 Month Performance-3.68%-7.56%-5.66%-7.21%
1 Year Performance-63.52%-11.73%-1.17%-7.05%

OneMedNet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONMD
OneMedNet
2.1267 of 5 stars
$4.45
-10.1%
N/A-65.0%$30.70M$1.36MN/A23
CCLD
CareCloud
2.3925 of 5 stars
$2.62
-0.6%
N/A-20.1%$111.27M$120.50M20.123,650
HCAT
Health Catalyst
3.5081 of 5 stars
$1.42
-1.7%
$2.01
+41.9%
-40.6%$107.75M$311.14MN/A1,200
HIT
Health In Tech
1.5605 of 5 stars
$0.56
-5.5%
$3.50
+523.9%
-72.5%$36.70M$32.83MN/A91
DRIO
DarioHealth
2.9053 of 5 stars
$2.35
-1.7%
$9.00
+283.1%
-89.0%$23.01M$22.36MN/A165

Related Companies and Tools


This page (NASDAQ:ONMD) was last updated on 11/19/2026 by MarketBeat.com Staff.
From Our Partners